Skip to main content

QGEN

Stock
Health Care
Diagnostics & Research

Performance overview

QGEN Price
Price Chart

Forward-looking statistics

Beta
0.37
Risk
22.89%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Qiagen NV offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees6K
Market cap$9.9B

Fundamentals

Enterprise value$10.8B
Revenue$2.0B
Revenue per employee—
Profit margin4.68%
Debt to equity41.36

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$0.43
Dividend per share$0.25
Revenue per share$9.25
Avg trading volume (30 day)$68M
Avg trading volume (10 day)$66M
Put-call ratio—

Macro factor sensitivity

Growth-2.2
Credit+3.2
Liquidity+1.3
Inflation-3.8
Commodities-0.8
Interest Rates-1.4

Valuation

Dividend yield0.52%
PEG Ratio21.11
Price to sales5.23
P/E Ratio21.11
Enterprise Value to Revenue5.42
Price to book3.07

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend dayJuly 2, 2025

News

QGEN or EXAS: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Exact Sciences (EXAS). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research (July 10, 2025)
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company's growth and improve value

Management at Qiagen has done the hard things right, but there is now an opportunity for the company to grow faster and in a more focused way.

CNBC (May 3, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free